Shares of Tissue Regenix Group plc (LON:TRX – Get Free Report) hit a new 52-week low during trading on Wednesday . The stock traded as low as GBX 39 ($0.50) and last traded at GBX 40.90 ($0.53), with a volume of 31109 shares trading hands. The stock had previously closed at GBX 42.50 ($0.55).
Tissue Regenix Group Price Performance
The firm’s fifty day simple moving average is GBX 53.61 and its 200-day simple moving average is GBX 56.59. The firm has a market capitalization of £36.87 million, a PE ratio of -42.22 and a beta of 1.61. The company has a quick ratio of 2.36, a current ratio of 4.03 and a debt-to-equity ratio of 31.16.
About Tissue Regenix Group
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Recommended Stories
- Five stocks we like better than Tissue Regenix Group
- How to Invest in Blue Chip Stocks
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- How to Use the MarketBeat Dividend Calculator
- Why Energy Transfer Belongs on Your Watchlist
- Insider Trades May Not Tell You What You Think
- Why Wayfair Stock May Be a Hidden Gem for Value Investors
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
